"I learned to see life in a different way."
Dave, MS LifeLines Ambassador
Living with RRMS
Living Well with MS
Who's Your LifeLine?
MS Awareness Week is about joining forces and moving together toward a common goal—a world free of MS. But
the fuel for this journey is in the individual stories of hope, inspiration and often humor that help people connect
on a personal level. We know there are unsung heroes out there that inspire you—a friend with MS or a caregiver
who personifies the idea of living well—and we want to give you the opportunity to tell us all about them. Now
is your chance to let us know who inspires you.
Through the Who's Your LifeLine program, you can honor someone in your life who maintains a positive outlook
toward MS. When you tell us about your LifeLine in a short, 250-750 word essay, you give him or her the opportunity
to be featured on mslifelines.com. In honor of MS Awareness Week, MS LifeLines® wants to help one special
LifeLine get the recognition he or she deserves! That's why, later this year, we're going to feature one inspirational
story in a special, upcoming insert in Redbook Magazine.
Redbook Magazine is an inspirational lifestyle magazine with a circulation of more than 2,000,000 readers who
can be inspired by your LifeLine. Look for more information in the May issue of Redbook Magazine about how to submit
your inspirational story for a chance to have your LifeLine featured in an upcoming issue.
To learn more about Who's Your LifeLine, check out our latest
LifeLine Spotlight, featured on mslifelines.com.
Redbook Magazine is a registered trademark of Hearst Communication, Inc.
Brought to you by EMD Serono, Inc. and Pfizer Inc, the co-marketers of Rebif® (interferon beta-1a) in the US 
Prescribing Information - Medication Guide
This information is intended only for residents of the United States.
Rebif is used to treat relapsing forms of MS to decrease the frequency of relapses and delay the occurrence of some of the physical disability that is common in people with MS. Efficacy has been established in controlled studies up to 2 years in duration. Rebif is not approved for the treatment of chronic progressive multiple sclerosis. Rebif is available by prescription only in 22 mcg and 44 mcg pre-filled syringes and a titration pack.
Before beginning treatment, patients should discuss with their doctor the potential benefits and risks associated with Rebif. Let your doctor know if you have a history of depression, seizures, liver disease, thyroid problems, and blood count or bleeding problems or if you have had previous allergic reactions to medications. Tell your doctor about all medicines you take, including prescription and non-prescription medicines, vitamins and herbal supplements. Rebif and other medicines may affect each other causing serious side effects. Talk to your doctor before you take any new medicines. Rebif is not recommended for women who are or plan to become pregnant.
Potential serious side effects of Rebif include depression, liver problems, risk to pregnancy, injection site problems and severe allergic reactions. Allergic reactions are rare and may be associated with difficulty breathing and loss of consciousness, which requires immediate medical attention.
The most common side effects with Rebif are injection site reactions, flu-like symptoms (fever, chills, muscle aches, tiredness), depression, abdominal pain, increased liver enzymes, and blood cell count decreases. Let your doctor know immediately if you have any of these symptoms or feel sad, tired, hot or cold, experience hives, rashes, bruising, yellowing of the skin, or a change in body weight (gain or loss).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This information is not intended to replace discussions with your healthcare provider. For additional information about Rebif, please consult the Medication Guide or Prescribing Information and talk to your doctor. You can also call toll free 1-877-44-REBIF (1-877-447-3243). Rebif is available by prescription only.
MS LifeLines is an educational support service for people living with MS and their families. MS LifeLines and MS LifeLines Ambassadors are sponsored by EMD Serono, Inc. and Pfizer Inc.
Rebif, Rebiject II and MS LifeLines are registered trademarks and the Rebif logo is a trademark of EMD Serono, Inc. or its affiliates.
MS in Balance Your Life in Full is a service mark of EMD Serono, Inc. or its affiliates.
Copyright 2010 EMD Serono, Inc. All rights reserved.